Interpace Biosciences®, Inc. Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Tax Disclosure [Abstract]
(Benefit) provision for income tax	$ (714)	$ 14	$ (684)	$ 43
Effective income tax rate	16.90%	0.20%	5.80%	0.20%

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.